Meiji Yasuda Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.29M Sell
9,633
-3,013
-24% -$1.34M 0.21% 142
2025
Q1
$6.13M Sell
12,646
-617
-5% -$299K 0.25% 113
2024
Q4
$5.34M Buy
13,263
+193
+1% +$77.7K 0.2% 132
2024
Q3
$6.08M Buy
13,070
+160
+1% +$74.4K 0.23% 113
2024
Q2
$6.05M Buy
12,910
+7,032
+120% +$3.3M 0.25% 112
2024
Q1
$2.46M Sell
5,878
-3,381
-37% -$1.41M 0.1% 198
2023
Q4
$3.77M Buy
9,259
+944
+11% +$384K 0.17% 162
2023
Q3
$2.89M Buy
8,315
+3,046
+58% +$1.06M 0.14% 199
2023
Q2
$1.85M Sell
5,269
-65
-1% -$22.9K 0.09% 219
2023
Q1
$1.68M Sell
5,334
-3,716
-41% -$1.17M 0.09% 231
2022
Q4
$2.61K Sell
9,050
-10,840
-54% -$3.13K 0.13% 201
2022
Q3
$5.76M Sell
19,890
-381
-2% -$110K 0.34% 88
2022
Q2
$5.71M Sell
20,271
-1,851
-8% -$522K 0.33% 80
2022
Q1
$5.77M Sell
22,122
-1,084
-5% -$283K 0.32% 83
2021
Q4
$5.1M Buy
23,206
+271
+1% +$59.5K 0.32% 86
2021
Q3
$4.16M Buy
22,935
+410
+2% +$74.4K 0.3% 89
2021
Q2
$4.54M Sell
22,525
-202
-0.9% -$40.7K 0.22% 99
2021
Q1
$4.88M Buy
22,727
+1,154
+5% +$248K 0.36% 75
2020
Q4
$5.1M Buy
21,573
+5,650
+35% +$1.34M 0.5% 55
2020
Q3
$4.33M Sell
15,923
-2,000
-11% -$544K 0.48% 53
2020
Q2
$5.2M Buy
17,923
+13,109
+272% +$3.81M 0.49% 48
2020
Q1
$1.15M Sell
4,814
-1,720
-26% -$409K 0.22% 97
2019
Q4
$1.43M Sell
6,534
-2,450
-27% -$537K 0.12% 193
2019
Q3
$1.52M Buy
8,984
+1,025
+13% +$174K 0.12% 188
2019
Q2
$1.46M Buy
7,959
+780
+11% +$143K 0.12% 187
2019
Q1
$1.32M Buy
7,179
+1,550
+28% +$285K 0.11% 201
2018
Q4
$933K Sell
5,629
-90
-2% -$14.9K 0.09% 244
2018
Q3
$1.1M Buy
5,719
+590
+12% +$114K 0.09% 234
2018
Q2
$872K Sell
5,129
-1,380
-21% -$235K 0.08% 267
2018
Q1
$1.06M Buy
6,509
+2,800
+75% +$456K 0.1% 235
2017
Q4
$556K Hold
3,709
0.05% 356
2017
Q3
$564K Sell
3,709
-1,700
-31% -$259K 0.06% 335
2017
Q2
$697K Buy
5,409
+2,200
+69% +$283K 0.07% 284
2017
Q1
$351K Hold
3,209
0.04% 409
2016
Q4
$236K Hold
3,209
0.03% 449
2016
Q3
$280K Buy
3,209
+870
+37% +$75.9K 0.03% 422
2016
Q2
$201K Buy
+2,339
New +$201K 0.03% 429